Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

44 compounds · 36 comparisons · live prices

Research peptides, priced and explained.

Shop the Nordapep catalogue with the evidence, regulatory status and price per mg for every compound beside it, plus the comparisons, calculators and guides researchers use most.

Best value per mg right now

Price per mg →
GHK-Cu Vial
Nordapep from £59.32 · £0.59/mg
Buy
GHK-Cu Pen
Nordapep from £110.21 · £1.10/mg
Buy
GHK Skin Glow
Nordapep from £92.65 · £1.32/mg
Buy

Lowest price per mg across in-stock sizes. For in vitro research only.

Published evidence scale
Every compound rated 1–5 on a rubric anyone can check.
Regulatory status upfront
Approved, investigational or unapproved, stated plainly.
Live price per mg
Pulled hourly from Nordapep's catalogue.
Transparent ownership
Published by the Nordapep team, and we say so.

Shop Nordapep

Batch-tested research peptides

Live prices from the Nordapep catalogue, each with a Certificate of Analysis per batch. Open the wiki profile to check the evidence before you buy.

View the full shop
Pre-filled pen70mg

GHK Skin Glow

Purity: ≥ 99% (HPLC)

Nordapep from
£92.65
£1.32/mg
Buy →Research profile
Pre-filled pen100mg

GHK-Cu Pen

Purity: ≥ 99% (HPLC)

Nordapep from
£110.21
£1.10/mg
Buy →Research profile
Lyophilised vial100mg

GHK-Cu Vial

Purity: ≥ 99% (HPLC)

Nordapep from
£59.32
£0.59/mg
Buy →Research profile
Lyophilised vial10mg

MT1

Purity: ≥ 99% (HPLC)

Nordapep from
£33.88
£3.39/mg
Buy →Research profile
Lyophilised vial10mg

MT2

Purity: ≥ 99% (HPLC)

Nordapep from
£33.88
£3.39/mg
Buy →Research profile
Pre-filled pen15mg

Retatrutide 15 mg

Purity: ≥ 99% (HPLC)

Nordapep from
£185.31
£12.35/mg
Buy →Research profile
Pre-filled pen40mg

Retatrutide 40 mg

Purity: ≥ 99% (HPLC)

Nordapep from
£329.91
£8.25/mg
Buy →Research profile
Lyophilised vial10mg

Retatrutide Vial 10 mg

Purity: ≥ 99% (HPLC)

Nordapep from
£63.40
£6.34/mg
Buy →Research profile

Live Nordapep prices, refreshed hourly.

Head to head

Most-searched peptide comparisons

Each comparison sets two compounds side by side on mechanism, structure, evidence and price, then explains what actually separates them.

SemaglutidevsTirzepatide

The core difference is receptor coverage. Semaglutide acts on the GLP-1 receptor only; tirzepatide acts on both the GIP and GLP-1 receptors. Both are fatty-acid-modified for a long half-life and both are approved medicines, so both sit at the top of our evidence scale.

Read the comparison →
TirzepatidevsRetatrutide

Retatrutide adds glucagon-receptor activity to the GIP and GLP-1 activity that tirzepatide already has. That third receptor is the whole story of the comparison.

Read the comparison →
SemaglutidevsRetatrutide

This pairing spans the whole incretin story: one receptor versus three. Semaglutide is the established single-receptor medicine; retatrutide is the investigational triple agonist.

Read the comparison →
BPC-157vsTB-500

These are often mentioned together but are unrelated molecules. BPC-157 is a 15-residue peptide derived from a gastric-juice protein. TB-500 is a fragment of thymosin beta-4, an actin-regulating protein.

Read the comparison →
CJC-1295vsIpamorelin

They act on two different pituitary receptors. CJC-1295 is a GHRH analogue acting at the GHRH receptor; ipamorelin is a ghrelin-receptor agonist. That is why they are so often studied together rather than instead of each other.

Read the comparison →
PT-141vsMelanotan II

PT-141 was derived from melanotan II. The key difference is selectivity: melanotan II activates several melanocortin receptors broadly, while PT-141 acts more selectively on central receptors, mainly MC4R.

Read the comparison →
SemaxvsSelank

Both are Russian-developed heptapeptides that share a stabilising Pro-Gly-Pro tail, but their parent sequences differ. Semax comes from ACTH(4-10) and is studied for neurotrophic signalling; Selank comes from tuftsin and is studied for stress-response and GABAergic pathways.

Read the comparison →
LiraglutidevsSemaglutide

Both are acylated GLP-1 analogues that act on the GLP-1 receptor only, and both are approved medicines. The difference is in the engineering: semaglutide has a different N-terminal substitution and a longer fatty-diacid linker, which gives it a half-life of about a week against roughly 13 hours for liraglutide.

Read the comparison →
SemaglutidevsCagrilintide

These two act on different hormone systems. Semaglutide mimics GLP-1 and activates the GLP-1 receptor. Cagrilintide mimics amylin and activates amylin and calcitonin receptors. Both are acylated for a half-life of about a week.

Read the comparison →

Not sure where to start?

Find a compound by area, evidence and status

Answer a few quick questions and the peptide finder points you to the reference pages that fit. It filters the library; it never recommends a use.

Learn

Guides for researchers

All guides →

Browse

By research area

Our edge

An evidence scale, not hype

Most peptide sites call everything 'clinically studied'. We rate every compound on what the published literature actually contains, and show the rating next to the price.

Read the full methodology →
  1. 5
    Approved drug, phase 3 trials
    Semaglutide, Tirzepatide, PT-141, Liraglutide, Tesamorelin, Afamelanotide, Setmelanotide, Oxytocin, Exenatide, Pramlintide, Teriparatide, Abaloparatide, Teduglutide, Octreotide, Leuprolide
  2. 4
    Late-stage human trials
    Retatrutide, Cagrilintide, Thymosin alpha-1, SS-31, Survodutide, Mazdutide
  3. 3
    Early human trials
    LL-37, Kisspeptin-10, Sermorelin, GHRP-2, Gonadorelin, ARA 290
  4. 2
    Mostly animal and in vitro
    BPC-157, GHK-Cu, Semax, Selank, Melanotan II, CJC-1295, Ipamorelin, GHRP-6, MOTS-c, Hexarelin, AOD-9604, Humanin
  5. 1
    Limited, preclinical or single-group
    TB-500, Epithalon, IGF-1 LR3, DSIP, KPV

FAQ

Questions researchers ask

What is peptide.wiki?

A reference and comparison site for research peptides. Every compound page sets out structure, receptor targets, an evidence rating, regulatory status and current Nordapep pricing, and any two or three compounds can be compared side by side.

Who publishes peptide.wiki?

The team behind Nordapep. We say so on every page, and every buy link goes to Nordapep. The evidence ratings follow a published method that does not depend on what we sell.

How are the evidence ratings decided?

On a five-point scale from approved medicines with phase 3 trials (5) down to preclinical or single-group literature (1). The full rubric is on the methodology page.

Are these peptides for human use?

No. The compounds are described and supplied for in vitro laboratory research only. Some share a name with approved medicines, but research-grade material is not a medicine.

How current are the prices?

Prices are pulled from Nordapep's live catalogue and refreshed hourly. Always confirm the final price on Nordapep before ordering.

For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.